Biohaven Pharma (BHVN) Misses Q1 EPS by 4c

Biohaven Pharma (NYSE: BHVN) reported Q1 EPS of ($0.88), $0.04 worse than the analyst estimate of ($0.84).

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
• Accuray (ARAY) Tops Q4 EPS by 1c